SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-21-000072
Filing Date
2021-07-23
Accepted
2021-07-23 16:47:18
Documents
1
Period of Report
2021-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162707322191181.html 4  
1 FORM 4 wf-form4_162707322191181.xml 4 3722
  Complete submission text file 0000899866-21-000072.txt   5186
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address
Carino Tanisha (Reporting) CIK: 0001792124 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 211111422